LISATA THERAPEUTICS, INC. Increase (Decrease) in Deferred Income Taxes
LISATA THERAPEUTICS, INC. (LSTA) reported Increase (Decrease) in Deferred Income Taxes of -$49.53 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2017-05-15
- LISATA THERAPEUTICS, INC. increase (decrease) in deferred income taxes for the quarter ending 2017-03-31 was -$49.53K.
- LISATA THERAPEUTICS, INC. increase (decrease) in deferred income taxes for the quarter ending 2016-09-30 was -$46.95K.
- LISATA THERAPEUTICS, INC. increase (decrease) in deferred income taxes for the quarter ending 2016-06-30 was -$46.95K, a 101.27% decline year-over-year.
- LISATA THERAPEUTICS, INC. increase (decrease) in deferred income taxes for the quarter ending 2016-03-31 was -$53.38K.
| Period end | Increase (Decrease) in Deferred Income Taxes 3 month | Increase (Decrease) in Deferred Income Taxes 6 month | Increase (Decrease) in Deferred Income Taxes 6 month as first filed | Increase (Decrease) in Deferred Income Taxes 9 month | Increase (Decrease) in Deferred Income Taxes 9 month as first filed |
|---|---|---|---|---|---|
| 2017-03-31 | -$49.53K 10-Q · filed 2017-05-15 | ||||
| 2016-09-30 | -$46.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$93.91K derived: sum of 2 quarters · filed 2016-11-07 | -$147.29K 10-Q · filed 2016-11-07 | ||
| 2016-06-30 | -$46.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$100.33K 10-Q · filed 2016-08-09 | |||
| 2016-03-31 | -$53.38K 10-Q · filed 2017-05-15 | ||||
| 2015-09-30 | -$46.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $3.66M derived: sum of 2 quarters · filed 2016-11-07 | $3.61M 10-Q · filed 2016-11-07 | ||
| 2015-06-30 | $3.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $3.66M 10-Q · filed 2016-08-09 | |||
| 2015-03-31 | -$46.63K 10-Q · filed 2016-05-05 | ||||
| 2014-09-30 | $600.00K 10-Q · filed 2014-10-30 | $552.61K derived: sum of 2 quarters · filed 2015-08-06 | -$142.18K 10-Q · filed 2015-11-05 | ||
| 2014-06-30 | -$47.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$94.80K 10-Q · filed 2015-08-06 | |||
| 2014-03-31 | -$47.41K 10-Q · filed 2015-05-06 | ||||
| 2013-09-30 | -$44.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$492.32K derived: sum of 2 quarters · filed 2014-10-30 | -$492.32K 10-Q · filed 2014-10-30 | $492.32K 10-Q · filed 2013-11-07 | |
| 2013-06-30 | -$447.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$447.57K 10-Q · filed 2014-08-07 | $447.57K 10-Q · filed 2013-08-08 | ||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-08 | ||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $0.00 10-Q · filed 2013-11-07 | |||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |